Agilent Technologies has selected Fluor Corporation to expand its oligonucleotide therapeutics manufacturing facility in Colorado, USA. The unit will include state-of-the-art engineering enhancements such as advanced automation, water reduction strategies and solvent capturing to optimize cost and construction.